Back to top

Image: Bigstock

Delta's (DAL) April Traffic Increases, Load Factor Down

Read MoreHide Full Article

Delta Air Lines, Inc. (DAL - Free Report) reported traffic figures for April 2018. Consolidated traffic, measured in revenue passenger miles (RPMs), came in at 18.26 billion, up 3.7% year over year.

Consolidated capacity (or available seat miles/ASMs) climbed 4% to 21.45 billion on a year-over-year basis. Consolidated load factor or percentage of seats filled by passengers contracted 20 basis points to 85.1% due to capacity expansion exceeding traffic growth.

Additionally, the carrier recorded an on-time performance (mainline) of 86.4% and completion factor (mainline) of 99.7% for the month. Approximately, 15.9 million passengers flew on Delta during the period.

In the first four months of 2018, Delta generated consolidated RPMs of 67.54 billion (up 3% year over year) and ASMs of 80.91 billion (up 3.1% year over year). Notably, load factor was 83.5%, unchanged from the tally in April 2017.

 

Last month, this Zacks Rank #3 (Hold) company reported first-quarter earnings and revenue figures. It surpassed the Zacks Consensus Estimate on both counts. However, the bottom line declined year over year on high fuel costs. Moreover, the winter storms, which caused multiple flight cancellations, hurt results. While the top line improved from the year-ago number on the back of strong demand for air travel. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key airline players like American Airlines Group Inc. (AAL - Free Report) , United Continental Holdings, Inc. (UAL - Free Report) and Southwest Airlines Co. (LUV - Free Report) also reported their respective financial figures last month. While United Continental posted better-than-expected results in the first quarter, American Airlines’ earnings bettered estimates but delivered lower-than-expected revenues. Meanwhile, Southwest Airlines’ bottom line in the first quarter matched the Zacks Consensus Estimate whereas revenues lagged the same.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

Published in